RXST

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 37.89 M33.64 M30.34 M32.61 M30.89 M33.74 M 127.58 M Gross profit 28.33 M25.19 M24.23 M25.26 M23.5 M25.68 M 98.67 M Operating expenses 39 M39.19 M36.41 M28.15 M41.33 M47.51 M 153.4 M Selling/general/admin expenses 28.64 M28.98 M27.34 M27.69 M31.86 M30.42 M 117.31 M Research & development 10.37 M10.22 M9.06 M8.9 M9.47 M9.24 M 36.67 M Operating income -10.67 M-14 M-12.18 M-11.34 M-17.83 M-13.77 M -55.11 M Non-Operating Income, Total 33 K79 K-45 K-14 K65 K5 000 11 K Interest expense, net of interest capitalized 6 0005 0004 0004 0003 0003 000 14 K Non-Operating Income, excl. Interest Expenses 27 K74 K-49 K-18 K62 K2 000 -3 000 Unusual income/expense —————— — Pretax income -8.17 M-11.75 M-9.81 M-9.15 M-15.88 M-12.01 M -46.84 M Equity in earnings —————— — Taxes 18 K32 K10 K6 0006 00088 K 110 K Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -8.19 M-11.79 M-9.82 M-9.15 M-15.88 M-12.1 M -46.95 M Discontinued operations —————— — Net income -8.19 M-11.79 M-9.82 M-9.15 M-15.88 M-12.1 M -46.95 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -8.19 M-11.79 M-9.82 M-9.15 M-15.88 M-12.1 M -46.95 M Basic earnings per share (Basic EPS) -0.2-0.29-0.24-0.22-0.38-0.29 -1.13 Diluted earnings per share (Diluted EPS) -0.2-0.29-0.24-0.22-0.38-0.29 -1.13 Average basic shares outstanding 40.51 M40.74 M40.97 M40.85 M41.31 M41.49 M — Diluted shares outstanding 40.51 M40.74 M40.97 M40.85 M41.31 M41.49 M — EBITDA 29.1 M-13.23 M-11.32 M-10.48 M24.33 M26.89 M 29.41 M EBIT 28.33 M-14.01 M-12.18 M-11.34 M23.5 M25.89 M 25.87 M Cost of revenue 9.59 M8.46 M6.11 M7.34 M7.39 M8.06 M 28.91 M Other cost of goods sold 31 K1.22 M66 K616 K60 K1.12 M 1.86 M Depreciation & amortization (cash flow) 776 K785 K854 K851 K834 K999 K 3.54 M